test

Jack Trottier

@Birchview Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$115.222MTotal holdings61
Assets growth rate6.73%Assets growth rate (2-Q avg)-2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Birchview Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 61 positions.

Assets under management

The assets under management (AUM) of Birchview Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 115.222M in assets, with a quarterly growth rate of 6.73% and a 2-quarter average growth rate of -2.56%. The portfolio is managed by Jack Trottier, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FHTXFoghorn Therapeutics Inc
Recent Activity
2.6%
$2.988M
320,930 shares@ $9.31 avg price
AXGNAxogen Inc
Recent Activity
2.4%
$2.762M
197,000 shares@ $14.02 avg price
PHRPhreesia Inc
Recent Activity
2.27%
$2.614M
114,700 shares@ $22.79 avg price
STOKStoke Therapeutics Inc
Recent Activity
2.24%
$2.581M
210,000 shares@ $12.29 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
1.88%
$2.16M
48,000 shares@ $45.0 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Increased 21.32%
1.8%
$2.071M
148,000 shares@ $13.99 avg price
MASIMasimo Corp
Recent Activity
1.77%
$2.037M
15,280 shares@ $133.33 avg price
OVVOvintiv Inc
Recent Activity
Decreased -29.64%
1.74%
$2M
52,200 shares@ $38.31 avg price
DCGODocgo Inc
Recent Activity
Increased 11.96%
1.49%
$1.71M
515,000 shares@ $3.32 avg price
CSTLCastle Biosciences Inc
Recent Activity
Increased 70.59%
1.44%
$1.654M
58,000 shares@ $28.52 avg price